Pharma & biotech · AAV gene therapies
REGENXBIO
About REGENXBIO
REGENXBIO is staffing a commercial organization ahead of its first launch: RGX-202, a one-time gene therapy for Duchenne muscular dystrophy, with a Hunter syndrome program (RGX-121) and a retinal program partnered with AbbVie behind it. The field team is not a classic rep force but regional market development directors (Central, Northeast, West), each living in the territory and working the neuromuscular treatment centers, the physicians who lead opinion in rare disease and the wider patient community, while coordinating sales, medical affairs, patient services and market access around the accounts. Market access runs its own key account work: a senior director builds the national and regional payer account team and negotiates coverage, including value-based contracts, with health plans, PBMs, specialty pharmacies, GPOs and integrated delivery networks. Above them sit a vice president who owns the rare disease franchise's P&L and the RGX-202 launch, reporting to the chief commercial officer, and a director of commercial data, analytics and forecasting who sizes the market, sets territory potential and field-force targeting and builds the patient-based launch forecast. These are senior hires: the postings ask for years of commercial, market development or customer engagement work in biotech or pharma, and the field seats travel their region regularly.
Stated by the company
, SalesJobs.Now shows 1 open REGENXBIO sales role.
REGENXBIO sales openings
Board read 14 Nov 2026, 01:06 UTCComparable sales openings elsewhere
The same sales role at other companies.
Senior Account Executive (opens the job details)
AlwaysHired · AE · El Segundo / Los Angeles, CA· 1w agoDetails
$100,000–$140,000/yrEnterprise Account Executive (opens the job details)
AlwaysHired · AE · New York, NY· 1w agoDetails
$140,000–$175,000/yrSMB/Mid-Market Account Executive (opens the job details)
AlwaysHired · AE · San Francisco, CA· 1w agoDetails
$130,000–$160,000/yrAccount Executive (Mid-Market) (opens the job details)
AlwaysHired · AE · Remote· 1w agoDetails
$120,000–$140,000/yr
If one of these employers pays a referral fee, it comes from them when you apply here, and your offer stays exactly the same.
- $245,000–$350,000/yr
SalesJobs.Now is free for job seekers. Some links here pay us: a job ad network pays for a click on one of its sponsored jobs, a recruiting firm pays a referral fee when someone who came from here is hired, and a career tool pays a commission when you buy it. That costs you nothing and never lowers what you are paid. Roles whose links pay us can be placed higher in a list. "Featured roles" are openings an employer picked during a free trial with us; no employer can pay for that spot.
Sponsored jobs from job networks, which pay SalesJobs.Now when you click one.
REGENXBIO openings by country
Where its sales openings take applicants, country by country.
REGENXBIO sales openings in your inbox
We look at REGENXBIO's careers page every 10 hours. Once a week you get its newest sales openings, plus close matches at other companies. Free, and one click stops it.
REGENXBIO as an employer
A Maryland gene therapy developer moving from clinical stage to commercial, hiring regional market development, payer account and franchise leaders for its Duchenne launch. Posted pay: Stated per posting (stated by the company).
1 sales opening on its careers board right now1 sales opening at REGENXBIO, as its own board showed them 14 Nov 2026.
Salaried employment with an annual bonus program, stock options at every level, a retirement plan with employer match, education assistance, summer hours and, on some postings, paid caregiver leave.
Right now 1 of its 1 open sales role are remote. Read from its postings on 30 Oct 2026: US only: field seats living in their region (Arizona for the Central region; New Jersey, Maryland or New York for the Northeast; California or Nevada for the West), remote US seats for payer accounts, commercial analytics and franchise leadership, and the Rockville, Maryland headquarters.
Caveats
- The pay figure is stated by the company: a reference point from research, not a salary read off today's postings, so negotiate from the offer in front of you.
Pay at REGENXBIO
Stated by the company, checked 2026-10-30From our research: stated by the company, checked 30 Oct 2026
Read from its postings on 30 Oct 2026: Every REGENXBIO commercial posting states an estimated annual base salary range, the same band in Lever's pay field and in the text, set by level rather than by location: the regional market development director seats carry the same band whichever region they cover. Variable pay is an annual bonus program, not commission, and no posting gives the target bonus as a share of base or the size of the stock option grant. Ask for the bonus target and what it pays on (company goals, launch milestones or regional performance), the option grant and its vesting, and, for the field seats, how a regional director is measured before RGX-202 is approved and selling. The roles listed below state what REGENXBIO posts now.
Only 1 of its 1 openings post pay, not enough to call a band typical for REGENXBIO, so the figure above comes from research. What each sales role posts:
| Sales role | Openings | Pay posted | Top posted |
|---|---|---|---|
| Account management | 1 | $245k–$350k/yr1 salary | $350k/yr |
Sales roles REGENXBIO hires for
Click a role to see what the job involves, which companies want it and what it posts for pay everywhere.
Breaking into sales? Read the guides first or see what every company posts for pay.
From the forum
Ask salespeople what REGENXBIO is like from the inside: comp, quota, the interview loop.
REGENXBIO: what candidates ask before applying
Is REGENXBIO a good company to sell for?
A Maryland gene therapy developer moving from clinical stage to commercial, hiring regional market development, payer account and franchise leaders for its Duchenne launch.
Is REGENXBIO still an active employer?
Yes. A Maryland gene therapy developer moving from clinical stage to commercial, hiring regional market development, payer account and franchise leaders for its Duchenne launch. How its pay is structured: Salaried employment with an annual bonus program, stock options at every level, a retirement plan with employer match, education assistance, summer hours and, on some postings, paid caregiver leave.
What does a sales job at REGENXBIO pay?
Stated per posting. Every REGENXBIO commercial posting states an estimated annual base salary range, the same band in Lever's pay field and in the text, set by level rather than by location: the regional market development director seats carry the same band whichever region they cover. Variable pay is an annual bonus program, not commission, and no posting gives the target bonus as a share of base or the size of the stock option grant. Ask for the bonus target and what it pays on (company goals, launch milestones or regional performance), the option grant and its vesting, and, for the field seats, how a regional director is measured before RGX-202 is approved and selling.
Is selling for REGENXBIO worth it?
Posted pay at REGENXBIO: Stated per posting (stated by the company). Pharma sales suit reps who build trust with prescribers over many visits and keep to what a drug's label allows them to say.
How is REGENXBIO's sales comp put together?
Salaried employment with an annual bonus program, stock options at every level, a retirement plan with employer match, education assistance, summer hours and, on some postings, paid caregiver leave.
Where are REGENXBIO's sales roles based?
Right now 1 of its 1 open sales role are remote. Read from its postings on 30 Oct 2026: US only: field seats living in their region (Arizona for the Central region; New Jersey, Maryland or New York for the Northeast; California or Nevada for the West), remote US seats for payer accounts, commercial analytics and franchise leadership, and the Rockville, Maryland headquarters.
Weigh REGENXBIO against
Neuroscience biotech preparing the US launch of azetukalner, a Kv7 potassium channel opener for focal onset seizures now filed with the FDA, to neurologists, epilepsy centers, health systems, commercial and government payers.
$253k–$345k/yrTypical pay, live
Develops avexitide for post-bariatric hypoglycemia, plus programs in Wolfram syndrome and ALS, and is standing up the US field force that would sell the PBH drug.
$239k–$253k/yrTypical pay, live
Clinical-stage oncology drug developer preparing to sell varegacestat, a gamma secretase inhibitor for desmoid tumors under FDA review, to US oncologists, sarcoma specialists, health plans and PBMs.
$223k–$235k/yrTypical pay, live
Clinical-stage biotech developing lorundrostat, an oral once-daily aldosterone synthase inhibitor for uncontrolled and treatment-resistant hypertension, and building the field team that will sell it to the physicians who treat those patients.
$198k–$235k/yrTypical pay, liveCompanies are listed by what an application there is worth to you, and one that pays us a fee for hires sent from here gets a lift in that order; the fee never touches the base or OTE a company offers.
Hiring salespeople at REGENXBIO? See how to put your openings in front of the sellers who browse this board.